H. PYLORI-INFEKTsIYa: SOVREMENNYE REKOMENDATsII PO DIAGNOSTIKE I LEChENIYu
- Авторлар: Gratsianskaya A.N1
-
Мекемелер:
- Шығарылым: № 6 (2015)
- Беттер: 6-10
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/287846
- ID: 287846
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Аннотация
The article describes the basic approach to the treatment of H. pylori-infection in accordance with Maastricht recommendations. The main indicators characterizing the effectiveness of treatment are suggested. The tactics of treatment in case of resistance to the components of the conventional therapy is discussed in detail. The criteria, which are sufficient for H. pylori eradication to prevent gastric cancer, are proposed. The need to find the simple and reliable methods for determining the of H. pylori sensitivity to antibiotics without a biopsy of the gastric mucosa is emphasized.
Негізгі сөздер
Толық мәтін
Әдебиет тізімі
- Marshall B.J., Warren J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1983;1(8390): 1311-15.
- Current European concepts in the management of Heli-cobacter pylori infection. The Maastricht Consensus Report. Gut. 1997;41(1):8-13.
- Malfertheiner P., Megraud F., O'Morain C., Hungin A.P., Jones R., Axon A., Graham D.Y., Tytgat G.; European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Aliment. Pharmacol. Ther. 2002;16(2):167-80.
- Malfertheiner P., Megraud F., O'Morain C. Guidelines for the Management of Helicobacter Pylori Infection. European gastroenterology review. 2005.
- Guidelines Management of Helicobacter pylori infection - the Maastricht IV. Florence Consensus Report The European Helicobacter Study Group (EHSG). Gut. 2012;61:646.
- Лапина Т.Л. Эрадикационная терапия инфекций Helicobacter pylori. Медицинский вестник. 2006;16:9-10.
- Urgesi R., Cianci R., Riccioni M.E. Update on triple therapy for eradication of Helicobacter pylori: current status of the art. Clin. Exp. Gastroenterol. 2012;5:151-57.
- Heo J., Jeon S.W. Optimal treatment strategy for Helicobacter pylori: era of antibiotic resistance. World J. Gastroenterol. 2014;20(19): 5654-59.
- Kawai T., Yamagishi T., Yagi K. Kataoka M., Kawakami K., Sofuni A., Itoi T., Sakai Y., Moriyasu F., Osaka Y., Takagi Y., Aoki T., Rimbara E., Noguchi N., Sasatsu M. Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities. J. Gastroenterol. Hepatol. 2008;23(2):S171-74.
- Del Giudice G., Malfertheiner P., Rappuoli R. Development of vaccines against Helicobacter pylori. Expert. Rev. Vaccines. 2009;8: 1037-49.
- Aebischer T., Bumann D., Epple H.J., Metzger W., Schneider T., Cherepnev G., Walduck A.K., Kunkel D., Moos V., Loddenkemper C., Jiadze I., Panasyuk M., Stolte M., Graham D.Y., Zeitz M., Meyer T.F. Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a- based Salmonella vaccines. Gut. 2008;57: 1065-72.
Қосымша файлдар
